Final month, Israeli 3D printer producer Nano Dimension signed a non-binding time period sheet to merge with Infinite Epigenetics, an AI-powered preventive well being and diagnostics firm, in a proposed deal valued at $890 million. If accomplished, the transaction would mark the formal finish of Nano’s decade-long presence within the additive manufacturing sector, and the start of a brand new chapter in healthcare AI.
The deal isn’t but last: a 30-day exclusivity interval started for due diligence and negotiation of a definitive settlement, which can nonetheless require board, shareholder, and regulatory approval. That window has since closed, and, because the sections under element, the board that negotiated the deal has since been changed following a settlement with activist investor Murchinson Ltd.
A Pivot Years within the Making
For anybody watching Nano Dimension intently, this newest transfer might have been foreseeable.
Established within the early 2010s, the corporate initially marketed itself across the promise of “factories in a field,” compact desktop methods designed to print working circuit boards on demand. As our 2016 interview illustrated, {hardware} gross sales have been just one a part of the enterprise mannequin. Chatting with 3DPI’s Editor-in-Chief, Nano Dimension’s co-founder defined the logic behind what was described by us as “an uncommon method to financing.”
The offered purpose was sensible, if unconventional for the time. Conventional funding routes had closed off early. As co-founder Simon Fried defined on the time, the mix of superior {hardware}, complicated software program, and nano-chemistry was “too massive of a chunk for any angels and too dangerous for the VCs.” The corporate ultimately discovered personal traders prepared to again it, however solely on the situation that it function as a listed entity, giving them, in Fried’s phrases, a “liquidity get out clause.” The car they selected was a reverse merger on the Tel Aviv Inventory Change in 2014.
Reverse mergers, which use a public firm as a car to entry capital markets moderately than pursuing a conventional IPO, had fallen out of trend after changing into intently related to the wave of Chinese language firms that flooded U.S. exchanges within the early 2010s. The SEC responded by tightening itemizing guidelines, suspending buying and selling in dozens of these firms, and issuing formal warnings to retail traders. Consequently, the mid-2010s noticed a plateau within the variety of firms pursuing reverse mergers, prompting 3DPI’s curiosity in 2016.
For Nano Dimension, repeated rounds of ADS choices on Nasdaq constructed a considerable monetary reserve. By the primary quarter of 2021, Nano Dimension held $1.47 billion in money and equivalents, with $811,000 in quarterly income. That money pile attracted consideration: in January 2022, Murchinson Ltd., a Toronto-based activist funding fund, disclosed a minority stake in Nano and started pushing for board-level adjustments.
Murchinson’s intervention intensified the dispute over Nano Dimension’s technique and management of its money reserves. Within the interval that adopted, Nano expanded its acquisition exercise, which it offered as an effort to consolidate a fragmented AM market. The corporate described its steadiness sheet on the time as leaving it “ideally positioned to behave as a consolidator within the extremely fragmented market panorama.”
Beneath the management of former CEO Yoav Stern, Nano Dimension grew to become one in every of AM’s most aggressive consolidators, at one level launching a failed hostile takeover to purchase Stratasys. Ultimately, Nano Dimension assembled a portfolio spanning electronics printing, microscale manufacturing, and industrial metallic methods via acquisitions of Desktop Steel, Markforged, and Fabrica. The roll-up technique was a wager that scale might validate what natural progress had not. It finally failed to provide a sturdy consolidated AM group: Desktop Steel entered chapter proceedings, whereas Nano offered or discontinued a number of different companies and product strains, together with Fabrica. It has additionally agreed to promote most of Markforged to Stratasys, though that transaction has not but closed.
Nano Dimension Plans 3D Printing Exit
The newest announcement landed on June 15, 2026, following a multi-month strategic evaluation that assessed round 20 firms throughout a number of sectors. Infinite Epigenetics was chosen as essentially the most compelling path to long-term worth creation, a conclusion Nano’s board reached after figuring out that the power illness diagnostics market, at over $90 billion, provided a basically bigger alternative than persevering with to scale inside additive manufacturing.
David Stehlin, then CEO of Nano Dimension, framed the choice in simple phrases: “Infinite Epigenetics represented essentially the most enticing alternative for us to boost shareholder worth. The corporate checked the important thing containers we have been on the lookout for: a confirmed know-how platform with revenue-generating operations, a big rising addressable market, world-class prospects and companions, and a powerful management group, skilled board members, and extremely achieved traders.”
The reversal, from aggressive consolidator to full exit, is hanging, and the board’s personal language makes the reasoning express: a follow-up press launch issued on June 16 states that “the power illness diagnostics market exceeds $90 billion, considerably bigger than the 3D printing trade.” That quantities to an unusually direct comparability between the perceived alternatives within the two sectors from an organization that spent years betting on AM progress.
The Standoff: Murchinson’s Objections and the Combat for the Board
The transaction was not with out inner friction. Murchinson argued the proposed merger resembled a SPAC and not using a redemption proper, and that it will dilute present shareholders by successfully handing Nano’s money and itemizing to a personal firm on unfavorable phrases. In response, Nano defended each its evaluation course of and the goal firm, pointing to Infinite Epigenetics’ operational credentials: a CLIA-certified laboratory, greater than 120,000 epigenetic samples collected since 2020, a community of over 7,500 healthcare suppliers, and analysis collaborations with Harvard, Yale, Duke, and Stanford. The board cited Precise Sciences and Tempus AI as public-market comparators that it believes display the business potential of the diagnostics mannequin.
Murchinson escalated by requisitioning an Extraordinary Normal Assembly (EGM) with the intent to switch a majority of Nano’s board, a direct problem to the proposed deal.
On July 9, forward of the scheduled July 31 EGM, Nano’s board printed a shareholder letter arguing that Murchinson’s push to switch three of 5 administrators would, in impact, hand it management of the complete board, since two of the three seats up for elimination had initially been Murchinson’s personal nominees. The letter additionally disclosed an unsolicited, all-cash competing provide from Tang Capital, acquired after the Infinite Epigenetics announcement, including a second potential path away from the present merger plan.
That combat by no means reached a vote. On July 20, Nano and Murchinson introduced a settlement: the July 31 EGM was cancelled, and 4 administrators, David Stehlin, the chief who had publicly championed the Infinite Epigenetics deal because the board’s best choice, together with Robert Pons, Joshua Rosensweig, and Andy Sriubas, resigned. Of their place, Nano appointed Murchinson’s three nominees: Paul Fruchthandler, Moshe Rozenbaum, and Eliezer “Eli” Tarlow.
The next day, on July 21, the reconstituted board named Rozenbaum interim CEO and Phillip Borenstein board chairman, with the corporate’s language shifting towards “enterprise continuity” and a contemporary analysis of “strategic priorities,” moderately than a reaffirmation of the Infinite Epigenetics transaction.
With Stehlin gone and a Murchinson-aligned board and CEO now in place, whether or not the Infinite Epigenetics merger proceeds on its unique phrases, is renegotiated, or offers method to the rival Tang Capital provide is, for the second, an open query.
What the Authentic Deal Phrases Regarded Like
The proposed merger with Infinite Epigenetics appeared to comply with the identical monetary logic because the acquisitions that preceded it. Seen structurally, the transaction would additionally redeploy Nano Dimension’s public itemizing and remaining capital into a personal healthcare firm, economically comparable in some respects to a reverse merger, though not a traditional SPAC transaction.
Beneath the phrases initially proposed in June, the mixed firm was to commerce on Nasdaq below the ticker “IEAI” and function below the Infinite Epigenetics title, with Dr. Matthew Dawson, co-founder and CEO of Infinite Epigenetics, anticipated on the time to guide the mixed entity.
Beneath the time period sheet, the fairness allotted to present Nano shareholders was to be calculated utilizing Nano’s estimated web money at closing plus a 20% premium, with the mixed entity projected to carry greater than $400 million in money. Nano’s remaining AM belongings have been to be positioned right into a liquidation belief, with shareholders receiving contingent worth rights on any proceeds from their disposal.
Nonetheless, with the board that negotiated these phrases now changed, and the Infinite Epigenetics transaction not but reaffirmed by the brand new Murchinson-aligned board, these phrases must be thought of provisional moderately than present, significantly with Tang Capital’s rival all-cash provide nonetheless into account.
The Public Itemizing as a Strategic Asset
The redeployment of a public itemizing and substantial money steadiness into a brand new enterprise isn’t unprecedented within the 3D printing sector. The trade has seen associated variations of this capital-markets playbook for greater than half a decade.
The wave started in 2020 and 2021, when SPAC mergers grew to become the dominant path to marketplace for AM firms. Desktop Steel merged with Trine Acquisition and went public in December 2020, elevating $580 million within the course of. The logic was simple: use a blank-check car’s itemizing and capital to speed up progress. Funding in 3D printing firms accounted for practically $11 billion value of SPAC transactions within the years that adopted. Markforged, Velo3D, and Shapeways all adopted the identical route, utilizing SPACs to entry Nasdaq and NYSE listings with out conventional IPOs.
The long-term outcomes steadily fell far wanting the valuations and progress expectations offered when these firms went public. Shapeways was delisted. Desktop Steel filed for chapter. Markforged was acquired by Nano Dimension for $115 million, a fraction of the valuation at which it had gone public.
The SPAC period introduced personal firms into public markets via blank-check automobiles. What’s now rising is its mirror: public firms whose boards conclude that their unique companies provide much less enticing prospects than alternatives in totally completely different industries.
Nano’s personal board upheaval, arriving barely a month after its healthcare pivot was introduced, is a reminder that this mirror-image maneuver carries its personal model of the SPAC period’s instability, management of the car, not simply its vacation spot, stays contested.
3D Printing Business is inviting audio system for its 2026 Additive Manufacturing Functions (AMA) sequence, overlaying Power, Healthcare, Automotive and Mobility, Aerospace, House and Protection, and Software program. Every on-line occasion focuses on actual manufacturing deployments, qualification, and provide chain integration. Practitioners considering contributing can full the decision for audio system kind right here.
To remain updated with the newest 3D printing information, don’t overlook to subscribe to the 3D Printing Business e-newsletter or comply with us on LinkedIn.
Discover the total Way forward for 3D Printing and Government Survey sequence from 3D Printing Business, that includes views from CEOs, engineers, and trade leaders on the industrialization of additive manufacturing, 3D printing trade traits 2026, qualification, provide chains, and additive manufacturing trade evaluation.
Featured picture reveals Nano Dimension places of work in Munich. Photograph by Michael Petch.
